Document Detail


Misoprostol and pregnancy: ever-increasing indications of effective usage.
MedLine Citation:
PMID:  14624219     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: The subject of misoprostol in the field of reproductive health care has courted much controversy. The aim of this review is to survey the literature published in this field over the past year, and to evaluate developments in this area. This article will cover termination of pregnancy, induction of labor and the issue of postpartum hemorrhage. RECENT FINDINGS: The use of misoprostol as a single agent remains of clinical value when mifepristone is unavailable. The sublingual and rectal routes are alternative modes of administration. For induction of labor, the optimum dose and route of misoprostol is still undetermined. Lower doses of between 20 microg to 40 microg may increase the safety profile for labor induction. Misoprostol may be a useful adjunct to the therapeutic options available for the prevention and treatment of postpartum hemorrhage. SUMMARY: There are many potential uses for misoprostol in pregnancy. However clinicians must judge the evidence and the emotive debate surrounding this field and decide how it will influence their clinical practice depending on the priorities of their own clinical circumstances.
Authors:
Amali U Lokugamage; Hazem E Refaey; Charles H Rodeck
Related Documents :
990229 - Termination of abnormal intrauterine pregnancies with intramuscular administration of d...
487809 - Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-de...
14692649 - Unilateral transverse arm defect with subterminal digital nubbins.
715059 - Prostaglandin f2alpha induced termination of pregnancy and its reversal by prolactin or...
7682909 - Mifepristone. a review of its pharmacodynamic and pharmacokinetic properties, and thera...
18624139 - Discrepancies in the laws on identifying foetal sex and terminating a pregnancy in india.
399489 - The effect on fertility of immunizing female sheep with ram sperm acrosin and hyaluroni...
19168209 - Pregnancies established from handmade cloned blastocysts reconstructed using skin fibro...
6162139 - Relation of glucose to alpha-fetoprotein in amniotic fluid.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in obstetrics & gynecology     Volume:  15     ISSN:  1040-872X     ISO Abbreviation:  Curr. Opin. Obstet. Gynecol.     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-11-18     Completed Date:  2004-08-10     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9007264     Medline TA:  Curr Opin Obstet Gynecol     Country:  England    
Other Details:
Languages:  eng     Pagination:  513-8     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Royal Free and University College London Medical School, UK. a.lokugamage@ucl.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / therapeutic use*
Abortion, Induced / methods*
Female
Humans
Labor, Induced / methods*
Misoprostol / therapeutic use*
Oxytocics / therapeutic use*
Postpartum Hemorrhage / drug therapy,  prevention & control,  therapy*
Pregnancy
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 0/Oxytocics; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pain in endometriosis: effectiveness of medical and surgical management.
Next Document:  Non-invasive methods of diagnosis of endometriosis.